Medicare Enrolled

Dr. Mashal Akhter, M.D.

Retina Specialist (Ophthalmology) Physician · Columbus, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Research-focused
262 NEIL AVE STE 220, Columbus, OH 43215
6144643937
In practice since 2015 (11 years)
NPI: 1669853743 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Akhter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Akhter? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Akhter

Dr. Mashal Akhter is a retina specialist physician in Columbus, OH, with 11 years of NPI registration. Based on federal Medicare data, Dr. Akhter performed 5,889 Medicare services across 1,177 unique beneficiaries.

Between the years covered by Open Payments, Dr. Akhter received a total of $102,937 from 21 pharmaceutical and/or device companies across 138 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Akhter is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ 5,889 Medicare services $102,937 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,889
Medicare services
Bottom 42% in OH for retina specialist (ophthalmology) physician
1,177
Unique beneficiaries
$118
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~535 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
3,300 $29 $50
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
757 $27 $100
Aflibercept eye injection (Eylea) 657 $689 $1,248
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
413 $86 $304
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
303 $60 $90
Unclassified biologic
A biologic product that does not have a specific HCPCS code assigned.
169 $320 $537
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
153 $111 $230
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
76 $1 $25
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
22 $32 $209
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
21 $16 $100
Injection into eye membrane
A procedure involving the injection of a drug or substance into the membrane that covers the eyeball.
18 $30 $211
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$102,937
Total received (2018-2024)
Avg $14,705/year across 7 years
Top 18% in OH for retina specialist (ophthalmology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
138
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Scientific / Research
Research funding and grants
$98,001 (95.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,936 (4.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,010
2023
$465
2022
$487
2021
$526
2020
$50,523
2019
$48,764
2018
$1,162

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$369
Genentech USA, Inc.
$324
Astellas Pharma US Inc
$120
Apellis Pharmaceuticals, Inc.
$104
ABBVIE INC.
$92
Top 3 companies account for 80.6% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Pharmaceuticals, Inc.
$98,001
Regeneron Healthcare Solutions, Inc.
$1,305
Novartis Pharmaceuticals Corporation
$664
Alcon Laboratories Inc
$541
Genentech USA, Inc.
$529
Alimera Sciences, Inc.
$347
Astellas Pharma US Inc
$213
Apellis Pharmaceuticals, Inc.
$172
Glaukos Corporation
$149
Alcon Vision LLC
$142
Mallinckrodt Enterprises LLC
$136
AbbVie, Inc.
$118
Shire North American Group Inc
$115
ABBVIE INC.
$113
EyePoint Pharmaceuticals US, Inc.
$110
Mallinckrodt LLC
$107
Johnson & Johnson Surgical Vision, Inc.
$46
Bausch & Lomb Americas Inc.
$45
AbbVie Inc.
$39
Bausch & Lomb, a division of Bausch Health US, LLC
$33
Spark Therapeutics, Inc.
$13
Top 3 companies account for 97.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AcrySof · BEOVU · Centurion · CyPass · DEXYCU · DUREZOL · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Humira · ILUVIEN · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · Iluvien · Izervay · ORA · OZURDEX · ReSTOR · Syfovre · TRAVATAN Z · VABYSMO · VYZULTA · Vabysmo · XIIDRA · XIPERE · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work.

Looking for a retina specialist physician in Columbus?
Compare retina specialist physicians in the Columbus area by procedure volume, costs, and industry payment transparency.
Browse retina specialist physicians nearby

Geographic Context

Retina specialist physicians within 10 mi
7
Per 100K population
0.5
County median income
$73,795
Nearest hospital
GRANT MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Akhter is a mixed practice specialist, with moderate Medicare volume, with research-focused industry engagement in the top 18% of OH peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Akhter experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Akhter performed 3,300 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Akhter receive payments from pharmaceutical companies?
Yes. Dr. Akhter received a total of $102,937 from 21 companies across 138 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Akhter's costs compare to other retina specialist physicians in Columbus?
Dr. Akhter's average Medicare payment per service is $118. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Akhter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →